ENZALUTAMIDE
Disclaimer: These predictions are for research purposes only. They do not constitute medical advice and require clinical validation.
Overview
| Property | Value |
|---|---|
| Drug Name | ENZALUTAMIDE |
| DrugBank ID | DB08899 |
| HSA Status | Registered with Health Sciences Authority |
| KG Predictions | 139 |
| DL Predictions (≥0.7) | 50 |
Predicted Indications
The following indications are predicted based on TxGNN knowledge graph analysis:
| Indication | Source | Evidence |
|---|---|---|
| cystic fibrosis | TxGNN Knowledge Graph | L5 |
| non-histaminic angioedema | TxGNN Knowledge Graph | L5 |
| lymphosarcoma | TxGNN Knowledge Graph | L5 |
| pediatric systemic lupus erythematosus | TxGNN Knowledge Graph | L5 |
| acute lymphoblastic/lymphocytic leukemia | TxGNN Knowledge Graph | L5 |
| erythema multiforme | TxGNN Knowledge Graph | L5 |
| acquired angioedema | TxGNN Knowledge Graph | L5 |
| lichen disease | TxGNN Knowledge Graph | L5 |
| chronic primary adrenal insufficiency | TxGNN Knowledge Graph | L5 |
| adrenocortical insufficiency | TxGNN Knowledge Graph | L5 |
Evidence Summary
External Resources
Generated by SgTxGNN on 2026-03-11